Viewing Study NCT06338995


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2025-12-31 @ 6:57 PM
Study NCT ID: NCT06338995
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2024-03-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module